Drug recall · August 12, 2020
Fentanyl Citrate Inj recall
Why: Lack of Assurance of Sterility; potential loose metal overseal crimp defects.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA NDC 0409-9094-12
- Lots / codes
Lots: Tray lot: 13405DK Vial lot: 13-405 DK Exp. 1JUL2021, Tray lot: 17096DK Vial lot: 17-096-DK Exp. 1NOV2021
- Quantity
- 19,144 vials
- Company
- Pfizer Inc., New York, NY
- Distribution
- United States including Puerto Rico
- Initiated
- July 20, 2020 · Voluntary: Firm initiated
- Classified
- August 4, 2020
- Reported
- August 12, 2020
- Ended
- December 8, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fentanyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.